Lactobacillus and Emla drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lactobacillus (lactobacillus) and Emla (lidocaine; prilocaine). Common drug interactions include oropharyngeal pain among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Lactobacillus and Emla. It is created by eHealthMe based on reports of 51 people who take the same drugs from the FDA, and is updated regularly.

What is Lactobacillus?

Lactobacillus has active ingredients of lactobacillus. It is often used in stomach discomfort. eHealthMe is studying from 5,854 Lactobacillus users. Check the latest studies of Lactobacillus.

What is Emla?

Emla has active ingredients of lidocaine; prilocaine. eHealthMe is studying from 5,276 Emla users. Check the latest studies of Emla.

On Jul, 08, 2026

51 people who take Lactobacillus and Emla together, and have interactions are studied.

Lactobacillus and Emla drug interactions.

What are the common drug interactions of Lactobacillus and Emla, by gender? *:

female:

Oropharyngeal pain
Otitis externa (external ear infection)
Otitis media (inflammation of the middle ear)
Paranasal sinus hypersecretion
Paronychia (infection in the tissues adjacent to a nail on a finger or toe)
Pulmonary embolism (blockage of the main artery of the lung)
Pulmonary fibrosis (formation or development of excess fibrous connective tissue (fibrosis) in the lungs)
Rash pruritic (redness with itching)
Respiratory tract infection
Sinus congestion (blockage of sinus)

male:

Dyspnoea (difficult or laboured respiration)
Diarrhoea
Musculoskeletal chest pain (pain in chest muscle or nerve or bones)
Night sweats (sweating in night)
Productive cough
Pruritus (severe itching of the skin)
Pseudomonas test positive
Pyrexia (fever)
Secretion discharge
Sputum discoloured

What are the common drug interactions of Lactobacillus and Emla, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)

10-19:

Abdominal pain
Viith nerve injury
Dysphagia (a condition in which swallowing is difficult or painful)
Myoclonus (a brief, involuntary twitching of a muscle or a group of muscles)
Oral candidiasis (fungal infection of mouth)
Periorbital oedema (swelling around the eyes)
Somnolence (a state of near-sleep, a strong desire for sleep)
Stomatitis (inflammation of mucous membrane of mouth)
Haematocrit decreased
Haemoglobin decreased

20-29:

Drug-induced liver injury (diseases of the liver that are caused by physician-prescribed medications)
Heart valve incompetence (heart's valves do not work correctly)
Mitral valve incompetence (inefficient heart valve)
Pulmonary arterial pressure increased
Right atrial dilatation (enlargement of the right atrium chamber of heart)
Tricuspid valve incompetence (inefficient heart valve)

30-39:

Asthenia (weakness)
Chest discomfort
Chest pain
Cough
Decreased appetite
Diarrhoea
Dyspnoea (difficult or laboured respiration)
Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
Headache (pain in head)
Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)

40-49:

Upper respiratory tract infection
Alcohol abuse
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Lung abscess (pus in lungs)
Throat irritation
Burning sensation
Headache (pain in head)
Infusion related reaction
Infusion site erythema (reddening of the skin at infusion site)
Infusion site pruritus (severe itching at infusion site)

50-59:

Disease progression
Hypersensitivity
Rash
Rash pruritic (redness with itching)
Alanine aminotransferase increased
Aspartate aminotransferase increased
Blood magnesium decreased
Chronic kidney disease
Diarrhoea
Drug-induced liver injury (diseases of the liver that are caused by physician-prescribed medications)

60+:

Dyspnoea (difficult or laboured respiration)
Fatigue (feeling of tiredness)
Confusional state
Death
Device related infection
Dizziness
Ear infection fungal
Gastrointestinal fistula (an abnormal opening that allows the contents of the stomach or intestines to leak)
Glossodynia (a burning or painful sensation in the tongue)
Headache (pain in head)

What are the existing conditions these people have? *

Oral Candidiasis (fungal infection of mouth): 14 people, 27.45%
Pain: 13 people, 25.49%
Cough: 9 people, 17.65%
Cystic Fibrosis (disease of the secretary glands): 9 people, 17.65%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 9 people, 17.65%
Nausea (feeling of having an urge to vomit): 9 people, 17.65%
Wheezing (a high-pitched whistling sound made while you breath): 8 people, 15.69%
Immunodeficiency Disorders: 8 people, 15.69%
Anaesthesia: 8 people, 15.69%
Stress And Anxiety: 8 people, 15.69%

* Approximation only. Some reports may have incomplete information.

Do you take Lactobacillus and Emla?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously